Amoy Diagnostics Co Ltd - Asset Resilience Ratio

Latest as of June 2026: 7.85%

Amoy Diagnostics Co Ltd (300685) has an Asset Resilience Ratio of 7.85% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Amoy Diagnostics Co Ltd (300685) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥173.83 Million

≈ $25.44 Million USD Cash + Short-term Investments

Total Assets

CN¥2.21 Billion

≈ $324.08 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Amoy Diagnostics Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Amoy Diagnostics Co Ltd.

Liquid Assets Composition Over Time

This chart breaks down Amoy Diagnostics Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Amoy Diagnostics Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥173.83 Million	7.85%
Total Liquid Assets	CN¥173.83 Million	7.85%

Asset Resilience Insights

Limited Liquidity: Amoy Diagnostics Co Ltd maintains only 7.85% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Amoy Diagnostics Co Ltd Industry Peers by Asset Resilience Ratio

Compare Amoy Diagnostics Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Green Cross Lab Cell Corporation KQ:144510	Diagnostics & Research	0.18%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%
Scope Fluidics SA WAR:SCP	Diagnostics & Research	16.51%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	13.42%
Check-Cap Ltd F:7CC	Diagnostics & Research	2.90%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%

Annual Asset Resilience Ratio for Amoy Diagnostics Co Ltd (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Amoy Diagnostics Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	11.75%	CN¥275.96 Million ≈ $40.38 Million	CN¥2.35 Billion ≈ $343.53 Million	-5.29pp
2024-12-31	17.04%	CN¥351.89 Million ≈ $51.49 Million	CN¥2.06 Billion ≈ $302.15 Million	-7.20pp
2023-12-31	24.25%	CN¥469.12 Million ≈ $68.65 Million	CN¥1.93 Billion ≈ $283.13 Million	+8.54pp
2022-12-31	15.71%	CN¥259.30 Million ≈ $37.94 Million	CN¥1.65 Billion ≈ $241.58 Million	-5.08pp
2021-12-31	20.78%	CN¥315.85 Million ≈ $46.22 Million	CN¥1.52 Billion ≈ $222.41 Million	-2.80pp
2020-12-31	23.58%	CN¥304.86 Million ≈ $44.61 Million	CN¥1.29 Billion ≈ $189.19 Million	+20.71pp
2019-12-31	2.87%	CN¥30.06 Million ≈ $4.40 Million	CN¥1.05 Billion ≈ $153.18 Million	+2.86pp
2018-12-31	0.01%	CN¥90.36K ≈ $13.22K	CN¥818.75 Million ≈ $119.81 Million	--

pp = percentage points

About Amoy Diagnostics Co Ltd

SHE:300685 China Diagnostics & Research

Market Cap

$956.17 Million

CN¥6.53 Billion CNY

Market Cap Rank

#9102 Global

#2230 in China

Share Price

CN¥16.75

Change (1 day)

-0.95%

52-Week Range

CN¥16.18 - CN¥23.82

All Time High

CN¥57.70